The Pathological Roles of β-adrenergic Receptors in Melanoma and Their Potential as Therapeutic Targets: A Systematic Review and Meta-analysis
Current Oncology Reports · 18.11.2026 · 28 (1)
DOI: 10.1007/s11912-026-01868-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Current Oncology Reports, online erschienen am 18.11.2026. Verfasst von Nguyen Dac Thuy Luong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centenary Institute, The University of Sydney, Missenden Rd, Camperdown, NSW, Australia. Hauptthemen laut MEDLINE: Melanoma, Receptors, Adrenergic, beta, Adrenergic beta-Antagonists. Die Arbeit nennt 217 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Sydney.
Abstract (Originalsprache)
Purpose of Review β-adrenergic receptors (ADRBs) are key mediators of stress responses, which have important roles in cancer growth and dissemination. β-blockers, inhibitors of ADRBs that are well established for treating cardiovascular conditions, have been proposed to be potentially useful, cost-effective, repurposed drugs for treating various cancers, including melanomas. This study aims to critically appraise the evidence for the diverse roles of ADRBs in melanoma cell biology and pathogenesis, through a systematic review of the literature and a meta-analysis of clinical applications of β-blockers in melanoma patients. Recent Findings In vivo and in vitro experimental studies have shown β-blockers to have various beneficial effects on melanoma cell proliferation, tumor growth, differentiation, angiogenesis, metabolism, immune evasion, invasion and metastasis. However, many of these studies have used high drug concentrations that have questionable specificity for ADRBs and are clinically unattainable. The role of ADRBs in interactions between melanoma cells and tumor-infiltrating nerve and immune cells is being defined. Clinical application of β-blockers in melanoma patients may provide some progression-free survival benefit when taken prior to disease onset, indicating a role for ADRBs in melanoma progression. New approaches to administering β-blockers via synthetic particles are being developed to improve their effectiveness. Summary Our understanding of the importance of ADRBs in the pathogenesis and treatment of cancer has grown rapidly in recent years. ADRBs are at the nexus between the sympathetic nervous system and immune cells in melanomas. Determination of the optimal approach to implementing β-blockers to treat melanomas awaits further biological and clinical studies that will clarify their intrinsic effects and their interactions with existing treatments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Centenary Institute, The University of Sydney, Missenden Rd, Camperdown, NSW, Australia.
- Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
- Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
- Melanoma Institute Australia, Wollstonecraft, NSW, Australia.
- School of Life and Environmental Sciences, Charles Perkins Centre, The University of Sydney, Camperdown, NSW, Australia.
- Centenary Institute, The University of Sydney, Missenden Rd, Camperdown, NSW, Australia. guy.lyons@sydney.edu.au.
ORCID-Profile: Diona L Damian
Förderung
- The University of Sydney
Zitieren
APA
Luong, N. D. T., Teh, N., Saw, R. P. M., Neely, G. G., Damian, D. L., & Lyons, J. G. (2026). The Pathological Roles of β-adrenergic Receptors in Melanoma and Their Potential as Therapeutic Targets: A Systematic Review and Meta-analysis. Current Oncology Reports, 28(1). https://doi.org/10.1007/s11912-026-01868-2
Vancouver
Luong NDT, Teh N, Saw RPM, Neely GG, Damian DL, Lyons JG. The Pathological Roles of β-adrenergic Receptors in Melanoma and Their Potential as Therapeutic Targets: A Systematic Review and Meta-analysis. Current Oncology Reports. 2026;28(1). doi:10.1007/s11912-026-01868-2
BibTeX
@article{Luong2026,
author = {Luong, Nguyen Dac Thuy and Teh, Natalie and Saw, Robyn P M and Neely, G Gregory and Damian, Diona L and Lyons, J Guy},
title = {The Pathological Roles of β-adrenergic Receptors in Melanoma and Their Potential as Therapeutic Targets: A Systematic Review and Meta-analysis},
journal = {Current Oncology Reports},
year = {2026},
volume = {28},
number = {1},
doi = {10.1007/s11912-026-01868-2}
}
EUVIMED